US 12,274,981 B2
Membrane capsule
Todd J. Menkhaus, Dakota Dunes, SD (US); D. Craig Arnold, Dakota Dunes, SD (US); and Steven Schneiderman, Dakota Dunes, SD (US)
Assigned to NANOPAREIL, LLC, Comberton (GB)
Appl. No. 17/250,490
Filed by NANOPAREIL, LLC, Dakota Dunes, SD (US)
PCT Filed Jul. 29, 2019, PCT No. PCT/US2019/043847
§ 371(c)(1), (2) Date Jan. 27, 2021,
PCT Pub. No. WO2020/023952, PCT Pub. Date Jan. 30, 2020.
Claims priority of provisional application 62/711,160, filed on Jul. 27, 2018.
Prior Publication US 2022/0040641 A1, Feb. 10, 2022
Int. Cl. B01D 61/18 (2006.01); B01D 53/22 (2006.01); B01D 63/12 (2006.01); B01D 63/14 (2006.01)
CPC B01D 61/18 (2013.01) [B01D 53/228 (2013.01); B01D 63/12 (2013.01); B01D 63/14 (2013.01); B01D 2053/223 (2013.01); B01D 2201/291 (2013.01); B01D 2257/91 (2013.01); B01D 2313/105 (2013.01); B01D 2313/125 (2013.01); B01D 2313/44 (2013.01); B01D 2313/54 (2013.01); B01D 2319/02 (2013.01); B01D 2319/04 (2013.01)] 24 Claims
OG exemplary drawing
 
1. A system for biological and chemical separations, comprising:
a system inlet and a system outlet fluidly connected;
an array of membrane cartridges, each of the membrane cartridges comprising:
an elongated body enclosed within a sealed tubular housing;
an end cap providing a fluid port to the membrane cartridge within the tubular housing, wherein the membrane cartridge is positioned between the system inlet and the system outlet; wherein the fluid port is fluidly connected to the system inlet; and holes or slots in the elongated body;
wherein each of the membrane cartridges are arranged in parallel in the array.